Centurion Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Sell
1,110
-350
-24% -$68.7K 0.06% 259
2026
Q1
$286K Sell
1,460
-1
-0.1% -$194 0.06% 240
2025
Q4
$254K Buy
1,461
+1
+0.1% +$182 0.06% 259
2025
Q3
$278K Buy
+1,460
New +$259K 0.06% 235

Other funds holding DGX

Centurion Wealth Management's DGX Position: Q2 2026 in Review

Centurion Wealth Management reduced its Quest Diagnostics (DGX) stake by 24% in Q2 2026, selling an estimated $68.7K and leaving 1,110 shares worth $235K. The position accounts for 0.06% of the portfolio, ranked #259.

Centurion Wealth Management first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. The position peaked at $286K in Q1 2026. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Centurion Wealth Management held 1,110 shares of Quest Diagnostics worth $235K as of Q2 2026.
  • Centurion Wealth Management sold 350 Quest Diagnostics shares in Q2 2026, an estimated $68.7K.
  • Quest Diagnostics made up 0.06% of Centurion Wealth Management's portfolio in Q2 2026, its #259 holding.
  • Centurion Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • Centurion Wealth Management's Quest Diagnostics position peaked at $286K in Q1 2026.
  • 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.